Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Search

Page Path

HOME
Search

3

Long-term Follow-up of Patients Treated with Interferon Alfa for Chronic Hepatitis B

Jong Eun Yeon, M.D., Yeon Seok Seo, M.D., Yoon Hong Kim, M.D., Sang Hoon Park, M.D., Oh Sang Kwon, M.D., Kwan Soo Byun, M.D., and Chang Hong Lee, M.D.

Clin Mol Hepatol. 1999;5(1):12-21. Published online January 1, 2000

View: 2285 Download: 18

The Degree of TGF-p1 and a-SMA Expression in Liver Tissues with its Prognostic Value for the Therapeutic Efficacy of Interferon in Chronic Hepatitis B

Bai Young Kim, hee Jeong Ahn*, Seong Wook Oh, Oun Mi Jeong, Yu Jeong Choi, Jin Hwan Kook, Kyung Chul Kim, Sung Pyo Hong, Seong Gyu Hwang, Pil Won Park and Kyu Sung Rim

Clin Mol Hepatol. 1998;4(4):317-329. Published online January 1, 2000

View: 1966 Download: 13

Efficacy of Combination of Interferon α 2a , Ribavirin and UDCA in the Treatment of Chronic Hepatitis C

Dong Jin Suh , Neung Hwa Park , Young Hwa Chung , Young Sang Lee

Clin Mol Hepatol. 1998;4(2):109-119.

View: 2404 Download: 14

Lipid Peroxidation in Chronic Liver Diseases Type B

Kyung Chul Kim , Kwan Sik Lee , Kwang Hyub Han , Won Choi , Chae Yoon Chon , Sang In Lee , Young Myung Moon , Jin Kyung Kang , In Suh Park , Hye Young Kim

Clin Mol Hepatol. 1997;3(1):40-49.

View: 2365 Download: 18

A Study on HBV Precore Mutant in Liver Tissues of Chronic Hepatitis B Patiets

Hae Chul Chung , Yeong Hong Park , Jung Myung Chung

Clin Mol Hepatol. 1996;2(2):145-159.

View: 2358 Download: 14

4

A Case of Hypothyroidism Induced by Alpha - Interferon Therapy for Chronic Hepatitis B

So Young Kwon , Jong Eun Yeon , Sei Hyun Baik , Jin Ho Kim , Young Tae Baik , Kwan Soo Byun , Chang Hong Lee

Clin Mol Hepatol. 1996;2(1):77-81.

View: 2126 Download: 12

Original Article

Phase 1 Trial of the Safety, Pharmacokinetics, and Antiviral Activity of EDP-514 in Untreated Viremic Chronic Hepatitis B Patients

Man-Fung Yuen, Wan-Long Chuang, Cheng-Yuan Peng, Wen-Juei Jeng, Wei-Wen Su, Ting-Tsung Chang, Chi-Yi Chen, Yao-Chun Hsu, Guy De La Rosa, Alaa Ahmad, Ed Luo, Annie L. Conery

Received December 16, 2023 Accepted March 25, 2024

DOI: https://doi.org/10.3350/cmh.2023.0535 [Accepted]

View: 499 Download: 52

Reply to Correspondence

Reply to “Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B”

Pin-Nan Cheng, Ming-Lung Yu

Received April 5, 2024 Accepted April 9, 2024

DOI: https://doi.org/10.3350/cmh.2024.0228 [Epub ahead of print]

View: 382 Download: 16

1 | 2 | 3 | 4 | 5 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

8.9
First decision

09 Days

Publication after acceptance

03 Days

*Last 12 months

MOST VIEWED (Last 6 months)

Viewed By 5914	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5290	MAFLD: How is it different from NAFLD?
Viewed By 4990	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4077	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4061	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

+more

MOST CITED (2022-2024)

Cited By 137	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 104	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 82	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 71	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 66	MAFLD: How is it different from NAFLD?

+more

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051 FAX: +82-2-703-0071 E-mail: kasl@kams.or.kr

COUNTER

TODAY : 1066

TOTAL : 1837920